ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 10:11AM EDT. Market open.
| Previous Close | 61.73 |
| Open | 61.61 |
| Bid | 61.59 x 100 |
| Ask | 62.73 x 100 |
| Day's Range | 61.55 - 62.46 |
| 52 Week Range | 44.27 - 70.81 |
| Volume | |
| Avg. Volume | 162,166 |
| Market Cap | 1.304B |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | 38.64 |
| EPS (TTM) | 1.61 |
| Earnings Date | Aug 07, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 81.60 |
ZacksBeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
Beigene's (BGNE) shares surge 32% in a month due to the label expansion of one of its key oncology drugs, Tevimbra, to treat three NSCLC indications, including first- and second-line use, in the EU.
ZacksHas Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year?
Here is how Acrivon Therapeutics, Inc. (ACRV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
ZacksDown -6.19% in 4 Weeks, Here's Why ANI (ANIP) Looks Ripe for a Turnaround
ANI (ANIP) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
© 2024 Yahoo. All rights reserved.